Glenmark's Goa plant gets FDA VAI classification
Glenmark's Goa facility receives VAI classification in FDA inspection. The U.S. FDA issued a VAI (Voluntary Action Indicated) status in the Establishment Inspection Report, signaling minor observations. This indicates the facility is largely compliant but may require corrective actions. No product recalls or major compliance failures were reported.
📊 STOCKS: $GLENMARK | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #FDA
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.